Schematic representation of histone-modifying factor recruitment on cccDNA minichromosomes in relation to viral protein HBx. In the presence of HBx, histone-modifying factors such as p300/CBP, Set1A, ...

Chronic liver disease is long-term liver damage that worsens over months to years. Ongoing inflammation can lead to fibrosis, which can progress to permanent scarring called cirrhosis. Common causes ...

Hepatitis, a widespread global infection, is often shrouded in misinformation and myths. Many mistakenly believe it can be transmitted through everyday interactions like sharing utensils, hugging, or ...

"HCC remains a major public health issue, disproportionately affecting minority populations and metropolitan US regions. Although multiple risk factors could also contribute to the mortality in ...

In 2020, bulevirtide (BLV) was conditionally approved for treating chronic hepatitis delta (CHD), an inflammation of the liver caused by hepatitis D virus (HDV). Now real-world studies of patients ...

Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases. The company is dedicated to educating ...